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Lead poisoning is a perennial and serious health problem around the world.  The 
daily widespread use of lead has dramatically increased the degree and longevity of its 
exposure to humans, exacerbating the task of lead poisoning treatment. Lead exerts 
adverse effects on cardiovascular, central nervous, renal, gastrointestinal, and 
reproductive systems.  
The common treatment for lead poisoning is chelation therapy.  Chelators were 
proposed to treat lead poisoning a very long time ago. However, chelators have severe 
side effects that could cause more problems, in addition to lead poisoning. Therefore, 
another group of drugs has been suggested --- antioxidants. This type of chemicals not 
only possesses the chelating abilities for lead cation, but also has only small side effects 
on tissues.  In addition, antioxidants are able to reduce the oxidative stress induced by 
lead so that a normal antioxidant defense system can be maintained in the human body. 
Vitamin C, Vitamin E, α-lipoic acid, β-carotene, and N-acetylcysteine are the common 
antioxidants used for treating lead poisoning. In recent years, a new chemical, N-
acetylcysteine amide, the amide form of NAC, has been synthesized and tested as a 
promising new drug to treat oxidative stress related disorders. 
This research has focused on comparing the chelating abilities that N-
acetylcysteine (NAC) and N-acetylcysteine amide (NACA) have for lead divalent cation. 
The complex forms of Pb-NAC and Pb-NACA were determined, followed by estimating 
the amount of lead chelated by these antioxidants. The results showed that there were 
multiple complex forms for both Pb-NAC and Pb-NACA, and that NACA has a higher 
affinity for lead than NAC. 
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Lead poisoning is a serious health problem world-wide. Lead and lead chemicals 
have been commonly used for multiple purposes in different areas over thousands of 
years.  Lead exposure emanates from sources such as paints (Mathee et al., 2007; Gould, 
2009), drinking water (Patrick, 2006), food, gasoline (Patrick, 2006), occupational 
hazards (Shobha et al., 2009), and etc. The widespread use of lead has resulted in lead 
poisoning becoming a very important toxicity issue. According to a statement issued by 
the Centers for Disease Control (CDC) in 1985, blood lead levels above 10 μg/dl would 
be a concern for human health. Children may develop problems in IQ, hearing, and 
overall developmental growth whereas adults could develop hypertension (Gurer et al., 
2000). With elevated blood lead levels ranging from 20 μg/dl to 50 μg / dl, an individual 
is likely to suffer from abnormal metabolism and cessation of the heme synthesis (Fonte 
et al., 2007). With much higher blood lead levels (above 50 μg / dl), neuropathy (Catton 






















































Lead poisoning continues to be a health threatening problem. Lead substances can 
affect human health by inhalation (Landrigan and Todd, 1994), ingestion (Handley et al., 
2007) and dermal contact. Lead is toxic to various organs and tissues, and will induce 
failure of certain enzyme functions and physiological processes in the body, such as the 
inhibition of heme synthesis (Zhao et al,. 2007), protein oxidation (Sandhir et al., 1994), 
and lipid peroxidation (Ribarow et al., 1981). A complete understanding of mechanisms 
governing these processes has not been achieved. However, there are several theories 
explaining the toxicity of lead.  
One mechanism proposed is that lead is able to oxidize glutathione (GSH) (Kidd, 
1997), resulting in an imbalance of the antioxidant defense system, and thereby inducing 
the generation of free radicals. Lead divalent cation has a strong binding capacity for 
sulfhydryl group-containing proteins and enzymes, and therefore would react with a thiol 
group containing proteins or enzymes to produce free radicals which would decrease 
GSH levels (Patrick, 2006), resulting in a decline in the GSH/GSSG ratio (Figure 2.1.). In 
this scenario, GSH is no longer a natural antioxidant that functions as scavenging reactive 
oxygen species (ROS), detoxifying carcinogens, and regulating metabolism and the 
immune system. Rather, the level of free radicals, such as hydrogen peroxide, hydroxyl 
radical, and lipid peroxide, will be significantly increased in response to the presence of 
Pb (II), resulting in oxidative stress (Gurer and Ercal, 2000).    
Another adverse effect is the failure of heme synthesis (Flora, 2008). Lead 
divalent cations are able to react with δ-aminolevulinic acid dehydratase (ALAD) 
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(Mitchell et al., 1977) and ferrochelatase. ALAD, a cytosolic sulfhydryl enzyme, will 
stop the conversion of two molecules of δ-aminolevulinic acid into porphobilinogen. 
Therefore, heme biosynthesis in the cell would be terminated at ALAD. Ferrochelatase, 
an enzyme in the last step of heme synthesis that occurs in the mitochondria, would have 
much less activity in the presence of lead ions. As a result, these two important enzymes 
in the heme synthesis would be greatly affected by lead, not being able to perform their 
normal functions (Figure 2.1). This abnormal process would, in turn, stimulate δ-
aminolevulinic acid synthetase. Thus, there would be an increased accumulation of ALA 
and a decreased formation of porphobilinogen.  
Accumulated ALA would induce ROS generation (Ryter, 2000). First, ALA 
molecules would be converted into the ALA enol form by tautomerization. Secondly, 
autoxidation of ALA enol generates an ALA• radical and a superoxide anion radical (O2˙
-
). ALA• would further oxidize into iminoALA and produce more superoxide anion 
radical, forming hydrogen peroxide (H2O2) and oxygen. The iminoALA would then react 
with H3O
+
, forming 2,4-dioxovaleric acid (DOVA) and ammonium ion. Then, the 
autoxidation of ALA with oxyhemoglobin [Hb-Fe(II)] would produce  met-hemoglobin 
and H2O2. The final step is the generation of hydroxyl radicals (•OH) through the metal 
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The major treatment for lead poisoning is chelation therapy (Porru and Alessio, 
1996), aimed to remove accumulated lead in the body. The first chelators, used in treating 
lead poisoning (Kety and Letonoff, 1941) were very effective in removing lead. 
Ethylenediamine tetraacetic acid (EDTA), a famous and common drug in lead poisoning 
treatment (Horowitz and Mirkin, 2001; Blanusa et al., 2005; Tzu et al., 2007), is capable 
of decreasing lead levels in tissue. In the 1950s, CaNa2EDTA, a derivative of EDTA, was 
first introduced for chelating Pb in acute lead poisoning (Flora et al., 1995). Later, British 
Anti Lewisite (BAL), and Meso-2, 3-dimercaptosuccinic acid (DMSA) (Xiaojun Fang 
and Quintus Fernando, 1993; Jie Zhang et al., 2004; Stangle et al., 2007) were also 
developed for use in chelating therapies for lead poisoning.  
However, these chelators have different adverse effects which are extremely 
harmful. For instance, CaNa2EDTA itself is toxic for the renal system (Purser et al., 
1983), because it will induce cell necrosis. In addition, CaNa2EDTA is not able to travel 
through cell membrane and, thus, cannot be used to eliminate lead in the cell. In addition, 
chelators, such as CaNa2EDTA, are not capable of decreasing reactive oxygen species 
(ROS) induced by lead, so the oxidative stress still exists in tissues even after chelation 
therapy is applied. As a result, it is necessary to find other kinds of drugs to treat lead 
poisoning. Antioxidants, such as Vitamin E and C, selenocystine (Sel) (Aykin-Burns et 
al., 2006), N-acetylcysteine (NAC),  N-acetylcysteine amide (NACA) (Aykin-Burns et 
al., 2005; Penugonda et al., 2006), the amide form of NAC,  and etc. were considered as 
promising drugs to treat lead toxicity, because antioxidants not only decrease the blood 
lead levels, but also help rebalance antioxidant defense systems. 
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The ideal antioxidant for treating lead poisoning should be: 1) nontoxic; 2) able to 
easily cross the cell membrane (in which case lead in the cell could be removed by 
antioxidants as well as in extracellular fluids); and 3) have a strong affinity to the lead 
divalent cation. 
In previous studies, the abilities of decreasing the lead concentration in vivo 
differed widely among various kinds of chelators and antioxidants. This study is aimed to 
test and compare the chelating ability of two antioxidants --- NAC and NACA, in vitro.  
The two molecules both have a thiol group, which makes possible the binding of Pb(II). 
NAC has a carboxylic group with a negative charge, while NACA has an amide group on 
the same site (Figure 2.2). The difference of this one functional group in the molecule 





Figure 2.2. Molecular structures of N-acetylcysteine and N-acetylcysteine amide. 
 
 
The stoichiometry of a Pb-antioxidant complex can be delineated using a UV/vis 
spectrophotometer. Electrospray ionization mass spectrometry (ESI-MS) was adopted to 
reveal the structure information of Pb-antioxidant complexes. The amount of lead that 
N-acetylcysteine N-acetylcysteine amide 
8 
was complexed can be detected by using high performance liquid chromatography 
(HPLC) and X-ray electron spectroscopy (XPS).  
 
2.3. INSTRUMENTATION 
2.3.1.  Electrospray Ionization Mass Spectrometry (ESI-MS). Electrospray 
ionization mass spectrometry is a useful analytical technique. By ionization, analytes of 
interest can be detected by a mass spectrometer. ESI-MS is very useful to detect 
macromolecules (Claudia Bich and Renato Zenobi, 2009) without any fragmentation.   
2.3.1.1.  Theory.  Analytes will be first ionized after injection by a high voltage 
needle, and have certain charges on them without fragmentation. Therefore, the mass – to 
- charge (m/z) ratio of a molecule in the samples will be unique to others. With its 
particular m/z ratio, an analyte could be detected by a mass spectrometer.  
2.3.1.2.  Procedure.  Sample solutions will first be atomized using a high voltage 
needle, during which the analytes become ions with certain charges, because there is a 
strong electrical field during introduction. Then these ions will enter through a drying gas 
phase and two pumping stages, at which the ions are separated in the mass analyzer by 
different m/z ratios. With a mass spectrometer, the analytes could be detected 
individually by their mass to charge ratio (Figure 2.3).   
2.3.1.3.  Electrospray and ionization.  Analytes in samples will be introduced 
into to the instrument by a capillary needle, which is applied with a very high voltage, 
usually from 2 – 5 kV. Then there is a gradient electric – field for the generation of 
analytes ionization before the drying gas phase. The voltage on the capillary needle could 
be either positive or negative. However, the mechanism of the ionization process is not 
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totally understood. It has been suggested that the production of ionic form analytes occurs 
through two possible models: the ion evaporation model (IEM) and the charged residue 
model (CRM).  In the ion evaporation model, ions are released when the Coulombic 
repulsion is large enough to overcome the liquid’s surface tension (Iribarne and 
Thomson, 1976). In the charged residue model, solution droplets will have charges when 
voltage is applied. When the Coulombic repulsion is equal to the surface tension of these 
droplets, the excess of positive or negative charge in the droplets would be separated 
from the solution, resulting in  single ions (Taflin et al., 1989; Kebarle and Peschke, 









Figure 2.3. Schematic of electrospray ionization spectroscopy. 
 
 
By ionization, analytes of interest are added or removed by one proton, forming 
positively charged analytes (like [M + H]
+




gas phase analyzer 
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Figure 2.4. An ionization mechanism: the charged residue model. 
 
2.3.2.  X-ray Photoelectron Spectroscopy. X-ray photoelectron spectroscopy 
(XPS) is a surface analytical technique that non – destructively quantifies the elemental 
composition at the surface of a material at the topmost 50 – 100 Å and to provides 
chemical oxidation state information of the element examined (Hollander and Jolly, 
1970). 
2.3.2.1.  Theory.  When soft X-rays impinge onto the surface of a material being 
analyzed, the electrons in various valence orbitals will be ejected via a photoelectric 
effect.  The kinetic energy of these emitted electrons are measured and recorded, 
providing chemical information. 
X-ray photoelectron spectroscopy provides qualitative and quantitative 
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information about the surface of a material. Every elemental transition has its own 
characteristic kinetic energy, which appear in the binding energy spectra recorded by 
XPS. The binding energy range typically spans between 0 and 1250 eV. If a material 
contains carbon, and oxygen elements, there will be signal peaks at around 285 eV (Barr, 
1994), and 535 eV (Vaneica Y. Young and Kathryn R. Williams, 1999), respectively. The 
percentage of each element can be quantified by examining their normalized integrated 
peak areas.  
Small shifts in the binding energy indicate a different oxidation state of this 
particular element. Assuming that there are no final state effects, the chemical shift is 
arises from the coordination between this element and other elements in the same 
material. In Figure 2.5 (Siegbahn et al., 1967), the changes in the signal peak position are 
indicated in the binding energy spectra due to changes in the oxidation state at C1s orbital 
(Barr, 1994). In an electron deficient - environment, the binding energy increases; in an 
electron – rich environment the binding energy decreases (Hagstrom et al., 1964). 
2.3.2.2 Mechanism  The emission of photoelectrons is initiated by the irradiation 
of an X-ray with a certain known energy, hν (Figure 2.6).  Assuming the 1s orbital of 
element A, for example, has one photoelectron displaced by the X-ray beam, the reaction 
occurring for element A would be: 
A + hν            A+* + e
- 
In this equation, A is a certain atom, hν is the energy of the X-ray beam, A+* is a 
positively charged ion, and the electron, e
-





The kinetic energy could be calculated by X-ray photoelectron spectroscopy using 
the equation: 
KE = hv – BE – Φ 
KE stands for the kinetic energy of the emitted electron, hν for the energy of the 
X-ray beam, BE for the binding energy of the electron from a particular orbital being 
detected, and Φ for the work function of the spectrometer. The work function and the X-
ray energies remain constant when using the same instrument for measurement. 
Therefore, the binding energy of this element could be determined by:  
BE = hv – KE – Φ 
 
2.3.2.3 Instrumentation  A typical X-ray photoelectron spectroscopy system 
consists of an X-ray source, a sample holder, an analyzer, a detector and a place for 
detection within an ultra – high vacuum system (UHV) (Figure 2.7). 
In the set – up used to acquire the data in this thesis, monochromatic soft X-rays 
were produced by a Mg Kα anode (hν = 1253.6 eV).  A sample holder was maintained at 
a proper position in the ultra – high vacuum (UHV) for a suitable detection of electrons 
by the spectrometer. UHV conditions were required to insure the flight of photoelectrons 
into the detector analyzer and to reduce contamination on the material surface. The 
pressure of this vacuum system was maintained between 10
-8
 Torr to 10
-10
 Torr before, 
during and after analysis. The analyzer used for these experiments was a double-pass 
cylindrical mirror analyzer with two spherical grids. Electrons were retarded using these 
two grids to focus the photoelectrons into the detector. Usually two cylindrical mirror 
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3. MATERIALS AND METHODS 
3.1. CHEMICALS 
N-acetylcysteine amide was provided by Dr. Glenn Goldstein (David 
Pharmaceuticals, New York, NY, USA). High-performance liquid chromatography 
(HPLC) grade solvents and Na4EDTA were purchased from Fisher Scientific (Fair Lawn, 
NJ). All other chemicals including N-acetylcysteine, were purchased from Sigma - 
Aldrich (St. Louis, MO). 
 
3.2. DETERMINAITON OF THE STOICHIOMETRY OF Pb - ANTIOXIDANT  
COMPLEX 
 
A stock solution of lead acetate and antioxidants of the same concentration were 
prepared and maintained at a temperature between 0°C and 10°C. The volume ratio of 
Pb(II) and antioxidants varied from 7:1 to 1:3 according to Job’s method (MacCarthy et 
al., 1976). Job’s method is a quick and simple way to determine the stoichiometry of a 
complex. When the volume ratio of two molecules is equal to their stoichiometric ratio, 
the amount of the complex formed reveals a maximum. Figure 3.1 shows an example of 
which the absorbance reaches to the maximum when the volume of the two reacting 
molecules are at 1 to 1 ratio, so x, one molecule’s volume over the total volume, is equal 
to 0.5. The stoichiometry is 1: 1. Each sample was tested under UV light, between 









Figure 3.1. Determination of stoichiometry using Job’s method. 
 
 
3.3.  STRUCTURE INFORMATION OBTAINED FROM ESI-MS 
Lead acetate was dissolved with Na4EDTA, NAC, and NACA in doubly distilled 
deionized water with a 1:1 ratio, respectively. The solutions containing Pb-antioxidant 
complex were then analyzed by using a Thermo-Finnigan TSQ7000 triple-quadrupole 
mass spectrometer. The heated inlet capillary was kept at 250°C and the electrospray 
needle voltage was maintained at 4.5 kV. All voltages were chosen to maximize ion 
transmission and minimize unwanted fragmentation.  
 
3.4.  DETECTION OF COORDINATED LEAD – THIOL GROUPS IN THE 
ANTIOXIDANTS BY HPLC 
 
Sample solutions were prepared with Pb acetate and antioxidants at ratios of 0:1, 
0.5:1, 1:1, 2:1 and 4:1. These solutions were introduced into high performance liquid 
chromatography (HPLC). The HPLC system from Thermo Electron Corporation is 
composed by a Finnigan Surveyor autosampler Plus, a Finnigan Surveyor LC pump Plus, 
1 : 1 
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and a Finnigan Surveyor fluorescence Plus detector (λex=330 nm, and λex=376 nm). The 
HPLC column was a Reliasil C18 column (5 μm packing material) with 250×4.6 mm i.d. 
(Orochem technologies INC. Lombard, IL, USA).  
An isocratic program was used for Cysteamine hydrochloride testing. In this 
program, mobile phase A was composed of a volume ratio of 70:30 acetonitrile and 
HPLC- grade water, with 0.1% acetic acid and 0.1% o-phosphoric acid. The flow rate of 
this program was 1.000 ml/min, the percentage of mobile phase A was 100%, and the 
running time was 20 mins. 
A gradient separation method was used for the detection of NAC and NACA (Wu 
et al., 2006). Mobile phase A was composed of a volume ratio of 70:30 acetonitrile-
HPLC-H2O (v:v) with 0.05% acetic acid, and mobile phase B was composed of a volume 
ratio of 70:30 acetonitrile-HPLC-H2O (v:v) with 0.04% o-phosphoric acid.  
The running time for mobile phase A was from 0.1 min to 6.00 min, the flow rate 
was 0.7 ml/min, and the volume was 100%. The running time for mobile phase B was 
from 6.10 min to 10.00 min (Figure 3.2), the flow rate was 1.7 ml/min, and the volume 




Figure 3.2. A gradient method for NAC and NACA’s HPLC detection. 
 
 
Stock solutions of the studied antioxidants were prepared by dissolving 6.5 mg 
NAC (NACA: 6.5mg) in doubly distilled deionized water, making a concentration of 
1mM. This 1mM concentration of NAC was then diluted to produce 100μM, 10μM, 1μM 
and 0.1μM concentrations. Stock solutions of lead acetate were prepared by dissolving 
15.2 mg Pb acetate trihydrate in doubly distilled, deionized water, making a 1 mM Pb(II) 
solution. The 1 mM lead acetate was then diluted into 100 μM and 10 μM. 
A calibration experiment was performed first to elucidate the relationship of the 
peak area and the concentration, in which the concentrations varied: 2.5 nM, 12.5 nM, 25 












The experiment was divided into two parts, 0 hour and 1 hour time courses. For 
the 0 hour experiment, sample solutions were quickly prepared from the stock solution 
within 5 min; and then directly introduced to the autosampler system of the HPLC.  Table 
2 shows the components of sample solutions. In the case of the 1 hour experiment, a 
stock solution was incubated in a 37 °C water bath for 1 hour, and then used to prepare 
the remaining sample solutions. In all of the sample stock solutions, the concentration of 
NAC was 1 μM, and the concentration of lead acetate varied: 0, 0.5 μM, 1 μM, 2 μM and 
4 μM. These sample solutions were finally made into a 12.5 nM concentration solution. 
Table 2. Sample solution for HPLC detection 
Ratio of NAC : 
Pb 
Stock solution of NAC 
(ml) 




1 : 0 5.00 (1 μM) 0 0 
1 : 0.5 0.50(10 μM) 0.25 (10 μM) 4.25 
1 : 1 0.50 (10 μM) 0.50 (10 μM) 4.00 
1 : 2 0.50 (10 μM) 1.00 (10 μM) 3.50 
1 : 4 0.50 (10 μM) 2.00 (10 μM) 2.50 
 
 
Conc. (nM) Stock solution (μl) H2O (μl) NPM (μl) HCL (μl) 
0 0 250 750 10 
2.5 25.0 (0.1μM) 225.0 750 10 
12.5 12.5 (1μM) 237.5 750 10 
25 25.0 (1μM) 225.0 750 10 
50 50.0 (1μM) 200.0 750 10 
125 12.5 (10μM) 237.5 750 10 
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3.5. DETECTION OF THE PERCENTAGE OF LEAD BEING CHELATED BY 
USING  XPS 
 
X-ray photoelectron spectroscopy (XPS) was performed in an ion-pumped 
Perkin-Elmer PHI 560 system using a PHI 25-270AR double-pass cylindrical mirror 
analyzer. A magnesium Kα anode was operated at 15 kV and 250W with photon energy 
of 1253.6 eV. The system pressure did not exceed 1x10
–8
 Torr during scans. The pass 
energy used for high resolution XPS was 50 eV (0.1 eV/step and 90 ms/step). A 99.99% 
purity Ta foil (Cross Co., Moonachie, NJ) was used as a metal support for the Pb-
antioxidant film. A 0.1 ml aliquot of Pb acetate-antioxidant, with a ratio of 5:1 solution 
(lead acetate 2.5 mM : antioxidant 0.5 mM ) solution was loaded onto the 1cm x 1cm x 
0.1 mm square surface, and then introduced into a turbopumped antechamber to 
evaporate the liquid and outgas the sample prior to introduction into the UHV for XPS 
analysis. The Ta substrate (spot-welded to electrical leads from the sample probe) was 
cleaned by resistive heating by passing 12 amps through the Ta foil using a power supply 
(Hewlard – Packard 6259B DC power supply). The surface was heated to 1200 K, which 
sufficiently removed all of the Pb-antioxidant adsorbates. The C 1s level at 284.7 eV was 
used for charge correction (Barr, 1994).   
 
3.6.  POINT OF ZERO CHARGE VALUE DETERMINATION OF NAC AND   
NACA 
 
Solutions with pH values from 1 to 12 were prepared with HCl and NaOH 
solutions with 0.3 ml aliquots of each pH solution added into 5 ml glass tubes containing 
150 mg of NAC and NACA powder, respectively. The pH of each of the 12 tubes was 
measured by a pH meter. After a16 hour incubation in a refrigerator, the final pH values  
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of each tube was measured again and plotted to determine the point of zero charge values 
























4.1.  SEVERAL COMPLEX FORMS 
Structure information of a Pb-antioxidant complexes were obtained using UV - 
vis spectrophotometry and ESI – mass spectroscopy. Job’s method was applied to 
determine the stoichiometry of the Pb-antioxidant complex using a UV - vis 
spectrophotometer. Figure 4.1.A shows the spectra for signals of a Pb-Na4EDTA 
complex, indicating that 246 nm was the wavelength of maximum absorbance. According 
to Job’s method, x was 0.5, indicating that the stoichiometry of this complex was 1:1 
ratio. This result is consistent with the literature (Gupta et al., 2007). Figure 4.1.B depicts 
the result for a Pb-NAC complex, also from Job’s method. From the spectra, the highest 
absorbance of the signal was at 275 nm. The x was 0.286, so the stoichiometric ratio was 
2.5:1for Pb:NAC. Figure 4.1.C reveals the spectra of a Pb-NACA complex. There were 
the same as for the Pb-NAC complex, and 275 nm was the wavelength with the 
maximum absorbance. The x was 0.4; therefore, the stoichiometric ratio was 1.5:1for Pb-
NACA. 
The stoichiometries of Pb-NAC and Pb-NACA were very different from each 
other. The 2.5:1 ratio of Pb-NAC indicated that there was more than one single complex, 
which was the case with Pb-NACA with its stoichiometry of 1.5:1.  
Since there was more than one complex formed in Pb-NAC and Pb-NACA, it was 
not possible to determine their binding constants by just using UV-vis spectroscopy. Job’s 
method is only effective when only one complex formed in the solution, so an accurate 









Figure 4.1. Plot of Job’s method and spectra for a) Pb-EDTA complex; b) Pb-NAC 








Electrospray ionization, coupled with mass spectrometry (ESI-MS), was applied 
to detect the major complex in Pb-NAC and Pb-NACA complexes. Figure 4.2 shows the 
signal of [Na3EDTA-Pb]
+
 at 565.09 m/z, a 1:1 ratio of Pb(II) : EDTA in the complex. This 
result was consistent with the result obtained in the stoichiometry by using UV-vis 
spectrophotometry. Figure 4.3 was the spectra of signal for the Pb(II) and NAC solution. 
Pb(II) was able to coordinate with NAC by ratios of 1:1, 2:1, 2:2, and 3:2, resulting in a 
signal  for [Pb-NAC]
+
 at 369.77 m/z, a signal for [Pb-NAC-Pb-H2O]
+
 at 591.82 m/z, a 
signal for [NAC-Pb-NAC-Pb]
+
 at 736.80 m/z, and a signal for [Pb-NAC-Pb-NAC-Pb]
+
 at 
942.73 m/s. Their percentages of the total Pb-NAC complexes were 76.5%, 14.5%, 6.5%, 
and 2.5%, respectively. These complexes all contribute to the multi-form of Pb-NAC. 
Figure 4.4 reveals the spectra for the Pb acetate and NACA solution, in which case the 
signal was not the same as for  Pb-NAC. There were three major complex signals. One 
was a signal [Pb-NACA-H]
+
 at 368.93 m/z. Two other peaks were observed at 529.08 
m/z and 575.04 m/z for [Pb-(NACA-NACA)-H]
+
 and  [Pb-NACA-Pb]
+
. Their 




Figure 4.2. Spectra of a derivatized Pb-EDTA from ESI-MS. 
 
 





Figure 4.4. Spectra of a derivatized Pb-NACA from ESI-MS. 
 
Table 3. Composition of Pb-antioxidant complexes obtained from ESI-MS 
 Mass to charge ratio 
(m/z) 






























4.2. CHELATING ABILITIES 
Upon examination of the Pb-antioxidant complex forms and their relative 
abundances, it was possible to estimate the chelating abilities of N-acetylcysteine amide 
and N-acetylcysteine to lead divalent cation in vitro. 
The chelating ability was evaluated by quantifying the percentage that Pb(II) 
coordinated to the antioxidants. HPLC was applied to determine the amount of 
antioxidants that had been coordinated. Cysteamine hydrochloride, NAC and NACA are 
mono-thiol antioxidants that contain a sulfur-hydrogen functional group. By adding N- 
(1-pyrenyl) maleimide (NPM) to the sample, the thiol group in the compounds 
coordinated with NPM, formed a highly fluorescent complex for detection. A gradient 
program was used for NAC and NACA in the HPLC system, so that the thiol group could 
be both qualified and quantified. In the case of Cysteamine, an isocratic program was 
applied. The retention times for NAC, NACA and Cysteamine were around 4.8 min, 5.2 
min and 17.2 min, respectively. Figure 4.5 shows the declining trend of Cysteamine with 
the increase of Pb acetate in a mixed solution. At a ratio of 1:1, there was a 19.0% 
decrease in free Cysteamine concentration without any incubation, and a 33.5% decline 
after 1 h incubation in a 37°C water-bath. Figure 4.6 also reveals a declining trend for 
available NAC by using more Pb acetate. At a ratio of 1:1, 10.4% NAC reacted with 
Pb(II) with no incubation, and 17.8% NAC with 1 h incubation in a 37°C water-bath. The 
results were the same with NACA (Figure 4.7). With the addition of more Pb(II) acetate, 
the decrease in free Cysteamine, NAC, and NACA was more obvious ( Table 4). In 
addition, there was a great difference in the amount of reacted antioxidants between no 
incubation and 1 hr incubation at 37°C temperature. There were more antioxidants being 
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coordinated with lead acetate after 1 h of incubation, indicating a time period for a 
reaction between the antioxidants and Pb(II). 
Based on the amount of antioxidants that chelate Pb(II) and the percentage of the 
major complex forms, the percentage of Pb(II) that had been reacted by NAC and NACA 
could be estimated. In Pb-NAC, the major part is [Pb-NAC]
+
 with 76.5%. In this 
complex, the ratio of Pb (II) to NAC was 1:1. From the results obtained from HPLC, the 
total NAC reacted was 10.1% at a 1:1 ratio to the group with no incubation. Therefore, 
the total amount of lead chelated in the complex [Pb-NAC]
+
 would be 
76.5%×1×10.1%=7.7%. The total amount of Pb (II) being bound by NAC was estimated 
by adding the percentage of lead reacted with all of the complex forms in the Pb-NAC 
solution. The amount of Pb(II) complexed would be 11.7%. The percentage of lead 
chelated by NACA was 21.8%. 
 
 





Figure 4.6. Amount of NAC available in the Pb(II) and NAC solution. 
 
 
Figure 4.7. Amount of NACA available in the Pb(II) and NACA solution. (The filled bar 







Table 4. Percentage of antioxidants that have been reacted with Pb(II) 
 1:0.5 1:1 1:2 1:4 
0h 1h 0h 1h 0h 1h 0h 1h 
NACA 25.5% 22.9% 21.7% 28.7% 25.4% 36.1% 29.7% 46.1% 
NAC 7.8% 16.0% 10.1% 15.5% 12.0% 17.4% 12.5% 23.3% 
Cysteamine 18.5% 29.1% 19.0% 33.5% 20.7% 24.1% 23.7% 34.8% 
 
X-ray photoelectron spectroscopy was also applied to evaluate the chelating 
abilities of antioxidants. The changes of binding energy at a Pb 4f orbital were observed 
by analyzing the peaks, and comparing them to the control group (Figure 4.8). There 
were two peaks at the Pb 4f orbital for the control group, due to the spin orbital coupling, 
which only contained lead acetate; the two peaks were at 138.4eV and 143.3eV. In the 
case of samples with Pb(II) dissolved with Na4EDTA, NAC and NACA separately, two 
additional peaks were around 138.4eV and 143.3eV, apart from the control group (Figure 
4.9, a graph for one Pb-NAC sample at a Pb 4f orbital). Therefore, four peaks of Pb 4f 
were curve-fitted for the sample groups, deconvoluted using the analysis software, 
CasaXPS VAMAS software version 2.2 (Devon, United Kingdom). The two additional 
peaks, not observed in the control, signified the oxidation state in which Pb was bound to 
the antioxidants.  
The Pb 4f chemical oxidation states were quantified by measuring their XPS 
integrated peak areas. The peaks of the control group at 138.4eV and 143.3eV were 
denoted as components A and B in solid lines, and the two additional peaks that appeared 
in the samples were components C and D in dot lines. The percentage of the area of 
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component C, plus that of component D, over the areas of all of the peaks, is equal to the 
percentage of Pb bound, as shown in the equation  
Percentage of Pb(II) bound =                                                    (10) 
The sum of the percentage of component C and component D is shown in Table 5, 
revealing the trend that NACA had a higher affinity with Pb (II), as compared to the 
Na4EDTA and NAC groups (Figure 4.10). In all of the sample groups, 5mM Pb acetate 
reacted with 1mM chelator/antioxidants. In the Na4EDTA group, 11.6% of Pb was bound, 
and in the NAC sample, 10.3% of Pb was bound, while in NACA, 21.6% of the lead was 
absorbed, twice the percentage of the Pb-Na4EDTA and Pb-NAC complexes.  
There was only one functional group difference between NAC and NACA. Since 
NACA is the amide form of NAC, it was anticipated that the two antioxidants would have 
similar chelating abilities to Pb(II). However, NACA had a much higher affinity to Pb(II), 
according to results from the XPS experiment. Thus, a study in determination of the point 
of zero charge was carried out to understand the underlying reason for this difference. 
 
4.3.  POINT OF ZERO CHARGE (PZC)VALUES 
Figure 4.11 shows the initial and final pH values for both NAC and NACA. The 
point of zero charge (PZC) for NAC was at pH=2.0, and for NACA, the pH was 5.1. The 
pH value of the sample solution, in which Pb(II) dissolves with antioxidants, was at pH 
4.6. From the perspective of surface chemistry, if a solid surface with a PZC is higher 
than that of the surrounding aqueous solution, the surface will become protonated  and 
adopt a positive charge. Conversely, a solid surface with a PZC lower than that of the 
surrounding solution is prone to be hydroxylated, adopting a negative surface charge.  
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Clear difference in PZC between NAC and NACA were observed. NACA’s point 
of zero charge value was higher than that of the sample solution, while NAC’s was lower 
than that of the solution. We attribute the greater amenability of Pb(II) absoption to the 
accumulation of positive charge on the NACA substrate. 
 








Figure 4.8. Control spectra for Pb 4f orbital. 
 
 Component C % Component D % C+D % 
EDTA 5.8 1.4% 5.8 2.8% 11.6 2.6% 
NAC 5.4 2.3% 5.3 1.3% 11.2 3.5% 






Figure 4.9. A sample spectra for Pb 4f orbital. This sample was composed of ratio 5:1 Pb   























































Conditions for complex 




Because of the harmful side effects of chelators, patients with low blood lead 
levels are encouraged to leave areas prone to lead exposure. Only individuals who have 
blood lead levels as high as 45 μg / dL or above, will be treated with chelation therapy. 
The recent application of antioxidants provides a better treatment for lead poisoning, 
because antioxidants are able to decrease the lead level, as well as relieve the oxidative 
stress being induced.  
N-acetylcysteine is the most popular drug among these antioxidants. This 
antioxidant can be well absorbed by human bodies, and can cause a further decline in 
blood lead levels. As a result, its amide form, N-acetylcysteine amide, is produced, which 
might be better for decreasing lead levels. Therefore, it is necessary to compare the 
chelating abilities of the two similar compounds in vitro. 
Based on the Job’s method, it was possible to determine the stoichiometry of a 
complex. However, this method was restricted to determining only one complex. The 
data from UV-vis spectroscopy showed the consistency with literature of the Pb-EDTA 
1:1 ratio stoichiometry, while the ratios of the Pb-NAC and Pb-NACA complexes were 
2.5:1 and 1.5:1 ratio, respectively. The ratios of Pb-NAC and Pb-NACA indicated that 
there were several complexes in the samples. As a result, it was not possible to determine 
the exact stoichiometries for the Pb-NAC and Pb-NACA complexes, or their binding 
constants, by using UV-vis spectroscopy. 
To further understand the coordination between Pb and the antioxidants, the 
molecular structures of Pb-NAC and Pb-NACA complexes were necessary. One of the 
ways was to determine the direct coordination between lead and the antioxidants by 
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making their crystals. Crystallization of the complexes had been unsuccessfully tried. 
Although conditions of experiment were changed, such as the concentrations of lead 
acetate and antioxidants in a solution, incubation temperature, time and solvent, there was 
no crystal formation in the end. Another way to determine coordination was to use ESI 
mass spectroscopy to detect the mass to charge ratio of a certain signal and to determine 
whether there is a lead isotope peak. Since this ESI-MS system produces positron, every 
signal peak stands for a compound with one positive charge. With the known molecular 
weight of lead acetate, Na4EDTA, N-acetylcysteine and N-acetylcysteine amide, the 
forms of the complexes were calculated and determined. From the results obtained, we 
found four complex forms in the Pb-NAC sample, with ratios of 1:1, 2:1, 2:2 and 3:2. 
Among them, the 1:1 ratio complex occupied the major part of the total complexes. In the 
case of Pb-NACA, there were three complex forms with 1:1, 1:2 and 2:1 ratios. The Pb-
NAC complex also had the 1:1 ratio form ass the major one, as in the Pb-NACA 
complex. After understanding the complex forms for Pb-NAC and Pb-NACA, a 
determination was made of the amount of lead chelated by the antioxidants, which 
required combination of data from ESI-MS and HPLC. The results of the HPLC 
experiment made it possible to estimate the percentage of antioxidants that had been 
reacted. Thus, the amount of lead reacted could be interpreted based on the relative 
abundance of the complex forms, and the ratios between the lead and NAC, NACA, and 
the antioxidants reacted. 
The use of X-ray photoelectron spectroscopy (XPS) allowed a quick, but efficient 
estimate of the chelating abilities of different antioxidants. The percentage of Pb(II) could 
be determined by using XPS, in which case it was not possible to know the composition 
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of the multi-complexes and their relative percentages. The trend of chelating abilities 
obtained from the XPS experiment was consistent with the combination results from the 
ESI-MS and HPLC experiments, along with a comparison of their different point of zero 
charge values. NACA was determined to be better than NAC in chelating Pb(II) in vitro. 
The usual way to calculate the chelating ability of a compound is involved in knowing 
the structure of a complex, as well as its reacted percentage. As a result, a wide range of 
techniques, such ESI-MS, UV-vis spectrophotometer, HPLC and etc. are required to 
detect the exact chelating ability of a complex. By using X-ray photoelectron 
spectroscopy, it was more convenient and quick to assess the differentiated chelating 
abilities among antioxidants. However, the data obtained from the XPS experiment is not 
an absolute value, as it was not able to describe the exact chelating abilities of NAC and 
NACA, because it is a semi-quantification method. Using XPS, it is only possible to 
determine the percentage of lead reacted, but the amount of oxidation states of lead could 
not be determined. Thus, this technique could only estimate the trend of chelating 
abilities of the antioxidants. It is reasonable to assume that XPS is not a technique to be 
used for quantification, since it can only roughly determine a value.  
Future research can be concentrated on an in vivo experiment that involves animal 
tests. An In vitro study comparing chelating abilities of NAC and NACA would be ideal 
for evaluation their relative efficacies in lead poisoning treatment, validating the 






Retention time for Cysteamine, NAC and NACA in HPLC Experiments 
 
Retention time for Cysteamine is at 17.2 minutes 
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